Search Result For: compounded semaglutide
Date: 2025/06/12 - 00:31
Healthy lifestyles may offset dementia, stroke risk linked to telomere length
A new study has found that dementia, stroke, and depression are more common in people with shorter telomeres — a biomarker of aging — but that healthy lifestyles may help mitigate this risk.
Date: 2025/06/07 - 05:00
GLP-1 Drugs Linked to Age-Related Macular Degeneration, Study Finds
GLP-1 drugs like Ozempic are associated with a higher risk of developing wet age-related macular degeneration in people with type 2 diabetes, according to a new study. The risk increased the longer people were prescribed a GLP-1 drug, particularly those containing semaglutide.
Date: 2025/06/06 - 01:32
‘Ozempic Teeth’ May Cause Tooth Decay, Other Dental Health Effects
People using GLP-1 drugs like Ozempic are reporting "Ozempic teeth," an unusual side effect impacting dental health. "Ozempic teeth" may involve tooth decay, sensitivity, and tooth loss. Dentists cite dry mouth, vomiting, and low appetite as possible causes.
Date: 2025/05/19 - 22:32
Zepbound More Effective for Weight Loss Than Wegovy, Eli Lilly Trial Shows
Tirzepatide (Zepbound) led to more weight loss than semaglutide (Wegovy) in a clinical trial funded by Eli Lilly. Participants who received tirzepatide also had greater improvements in metabolic risk factors. Tirzepatide's dual effects on GLP-1 and GIP may explain its superior performance.
Date: 2025/05/18 - 16:31
Semaglutide may reduce heart disease risk, even within first 6 months
Semaglutide, available under the brand names Ozempic and Wegovy, may help decrease the risk of major adverse cardiovascular events after just six months of starting the medication, a new study indicates.
Date: 2025/05/15 - 23:32
FDA Accepts Novo Nordisk’s Application for Oral Wegovy: 5 Things to Know
Federal regulators have accepted Novo Nordisk’s application to produce a pill version of its injectable weight-loss medication Wegovy. Experts say an oral medication for weight loss might be more cost effective and easier for people to use.
Date: 2025/05/13 - 23:32
First-Generation GLP-1 Drugs May Help Lower Risk of Obesity-Related Cancers
First-generation GLP-1 weight-loss drugs can help reduce the risk of obesity-related cancers, new research shows. Liraglutide, exenatide, and dulaglutide were 41% more effective at preventing obesity-related cancers.
Date: 2025/05/05 - 23:00
Wegovy Reduced Inflammation, Scarring in People with Serious Liver Disease
Wegovy (semaglutide) could offer a new option to treat severe liver disease based on new clinical trial evidence. The GLP-1 drug resolved liver inflammation in nearly two-thirds of participants, twice the rate seen with placebo.
Date: 2025/04/29 - 23:00
Ozempic May Cause Cosmetic Side Effects Like Sagging Skin, Wrinkly Feet
"Ozempic feet" and "Ozempic mouth" are the latest reported cosmetic side effects from GLP-1 medications used for weight loss. Experts say wrinkles and sagging skin can result from rapid weight loss due to loss of fat and muscle mass in certain areas of the body.